Clinical trial
Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic…
NCT00004429 · FDA Office of Orphan Products Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00004429 |
|---|---|
| Title | Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis |
| Lead sponsor | FDA Office of Orphan Products Development, U.S. Fed |
| Collaborators | Vanderbilt University |
| Status | Completed |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | growth hormone |
| Enrollment | 25 |
| Start date | Dec 1, 1999 |
| Completion | Feb 1, 2005 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: